logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 4
  • 1
    Scraggs, Emily Anne, Dr
    Born in December 1968
    Individual (2 offsprings)
    Officer
    2014-04-02 ~ now
    OF - Director → CIF 0
  • 2
    Treherne, Jonathan Mark, Dr
    Born in July 1961
    Individual (21 offsprings)
    Officer
    2013-04-04 ~ now
    OF - Director → CIF 0
  • 3
    Livesey, Frederick John, Dr
    Born in August 1969
    Individual (2 offsprings)
    Officer
    2013-04-04 ~ now
    OF - Director → CIF 0
    Dr Frederick John Livesey
    Born in August 1969
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
  • 4
    Shah, Sunil Rajen
    Director born in July 1973
    Individual (27 offsprings)
    Officer
    2014-04-05 ~ 2016-09-20
    OF - Director → CIF 0
parent relation
Company in focus

TALISMAN THERAPEUTICS LIMITED

Period: 2013-04-04 ~ now
Company number: 08473331
Registered name
TALISMAN THERAPEUTICS LIMITED - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
152024-05-01 ~ 2025-04-30
142023-05-01 ~ 2024-04-30
Property, Plant & Equipment
149,899 GBP2025-04-30
91,328 GBP2024-04-30
Fixed Assets
149,899 GBP2025-04-30
91,328 GBP2024-04-30
Debtors
Current
728,007 GBP2025-04-30
520,716 GBP2024-04-30
Cash at bank and in hand
69 GBP2025-04-30
21,551 GBP2024-04-30
Current Assets
728,076 GBP2025-04-30
542,267 GBP2024-04-30
Creditors
Current, Amounts falling due within one year
-234,337 GBP2025-04-30
Net Current Assets/Liabilities
493,739 GBP2025-04-30
337,142 GBP2024-04-30
Total Assets Less Current Liabilities
643,638 GBP2025-04-30
428,470 GBP2024-04-30
Net Assets/Liabilities
641,237 GBP2025-04-30
428,470 GBP2024-04-30
Equity
Called up share capital
116 GBP2025-04-30
116 GBP2024-04-30
Share premium
34,983 GBP2025-04-30
34,983 GBP2024-04-30
Retained earnings (accumulated losses)
606,138 GBP2025-04-30
393,371 GBP2024-04-30
Equity
641,237 GBP2025-04-30
428,470 GBP2024-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
301,307 GBP2025-04-30
219,180 GBP2024-04-30
Property, Plant & Equipment - Other Disposals
Plant and equipment
-18,819 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
127,852 GBP2024-04-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-18,450 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
151,408 GBP2025-04-30
Property, Plant & Equipment
Plant and equipment
149,899 GBP2025-04-30
91,328 GBP2024-04-30
Trade Debtors/Trade Receivables
Current
229,500 GBP2025-04-30
201,479 GBP2024-04-30
Other Debtors
Current
243,301 GBP2025-04-30
186,677 GBP2024-04-30
Prepayments/Accrued Income
Current
255,206 GBP2025-04-30
105,018 GBP2024-04-30
Debtors - Deferred Tax Asset
Current
27,542 GBP2024-04-30
Bank Overdrafts
Current
41,445 GBP2025-04-30
Trade Creditors/Trade Payables
Current
55,385 GBP2025-04-30
54,880 GBP2024-04-30
Taxation/Social Security Payable
Current
23,339 GBP2025-04-30
22,791 GBP2024-04-30
Finance Lease Liabilities - Total Present Value
Current
24,447 GBP2025-04-30
Other Creditors
Current
3,039 GBP2025-04-30
2,561 GBP2024-04-30
Accrued Liabilities/Deferred Income
Current
86,682 GBP2025-04-30
124,893 GBP2024-04-30
Creditors
Current
234,337 GBP2025-04-30
205,125 GBP2024-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
62,244 GBP2025-04-30
155,610 GBP2024-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
62,244 GBP2025-04-30
155,610 GBP2024-04-30

  • TALISMAN THERAPEUTICS LIMITED
    Info
    Registered number 08473331
    Babraham Hall, Babraham Research Campus, Cambridge CB22 3AT
    PRIVATE LIMITED COMPANY incorporated on 2013-04-04 (13 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-18
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.